The 40th call for collaborative R&I projects is now open!
Launching of the 40th call for collaborative R&I projects
Do you have an innovative project idea and are you looking for partners to make it concrete? Your project is part of one of the strategic themes supported by the cluster, i.e:
- (bio)pharmacy (including cell and gene therapy and the industrial production of biomedicines)
- radiation applied to health
- medical devices and in vitro diagnostics
- digital health
Note: The ATMP theme is not eligible for the 40th project call.
These themes are in line with the Stratégie de la Spécialisation Intelligente (S3)* and more particularly with the roadmap of the Domaine d’Innovation Stratégique (DIS) 2*, “Innovations pour une santé renforcée” set up by the Region.
The BioWin team, through a well-established process, helps you to transform your project idea into a solid proposal that meets the criteria of the regional authorities through consolidation, critical review and monitoring of the projects.
Don’t wait any longer and apply to this new call! You have until 24 July 2023 to send us your letter of intent.
Below you will find the documents you need to submit your project
Presentation of the call 40
Outline of the letter of intent
Do you have a question? Do not hesitate to contact our R&I team:
Loïc Germain +32 472 65 43 02 Loic.germain[at]biowin.org
Marianne Ghyoot +32 484 90 47 12 Marianne.ghyoot[at]biowin.org
Thierry Ferain +32 486 49 91 92 thierry.ferain[at]biowin.org
*For more information about the S3 and the DIS 2 :
S3: Stratégie de Spécialisation Intelligente
DIS 2: Innovations pour une santé renforcée